Stonepine Capital Management, LLC
CIK
1440771
Location
BEND, OR
Portfolio Value
Small
$364,916,189
Diversification
Highly concentrated
Filing Date
Global Rank
#3,087
/ 8,603
▼ 91
· as of Mar 2026
Top Industry
Biotechnology
93.0%
3Y Alpha vs SPY
-10.9%
Period ended 3 months ago
Filed May 15, 2026 · 55d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+34.1%
SPY
+76.0%
Annualised alpha
-10.4%
Max drawdown
−61.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
69 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
60.1%
−6.6 pts
Top 5
76.3%
−3.2 pts
Top 10
83.4%
−1.5 pts
HHI
3,699
Highly concentrated−814
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.4% | $362,595,189 |
| Real Estate | 0.6% | $2,321,000 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
20 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CRIS | Curis Inc | +3,667,057 | 3,726,406 | $2,049,523 | |
| HRTX | Heron Therapeutics, Inc. /De/ | +1,164,389 | 2,402,191 | $1,921,752 | |
| CAMP | Camp4 Therapeutics Corp | +1,160,728 | 1,389,622 | $6,128,233 | |
| ADMA | Adma Biologics, Inc. | +1,150,000 | 1,890,000 | $17,028,900 | |
| TENX | Tenax Therapeutics, Inc. | +963,316 | 975,200 | $15,593,448 | |
| VSTM | Verastem, Inc. | +570,221 | 3,302,300 | $17,502,190 | |
| KTTA | Pasithea Therapeutics Corp. | +556,239 | 831,301 | $616,825 | |
| EOLS | Evolus, Inc. | +547,503 | 2,179,091 | $8,956,064 | |
| MXCT | Maxcyte, Inc. | +535,655 | 1,004,673 | $706,285 | |
| INAB | In8bio, Inc. | +498,519 | 663,412 | $981,849 | |
| MNKD | Mannkind Corp | +429,941 | 516,300 | $1,264,935 | |
| LUNG | Pulmonx Corp | +281,888 | 768,288 | $991,091 | |
| TELA | TELA Bio, Inc. | +265,220 | 2,617,252 | $1,622,696 | |
| CDXS | Codexis, Inc. | +161,888 | 417,994 | $681,330 | |
| ANTX | AN2 Therapeutics, Inc. | +86,177 | 713,845 | $2,441,349 | |
| DCTH | Delcath Systems, Inc. | +72,768 | 100,000 | $928,000 | |
| PCSA | Processa Pharmaceuticals, Inc. | +42,677 | 55,000 | $138,875 | |
| CNSP | CNS Pharmaceuticals, Inc. | +12,173 | 61,000 | $145,790 | |
| BIOA | BioAge Labs, Inc. | +5,000 | 50,000 | $874,500 | |
| ACET | Adicet Bio, Inc. | +1,944 | 221,955 | $1,511,513 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | −1,390,945 | 957,202 | $1,608,099 | |
| ELDN | Eledon Pharmaceuticals, Inc. | −858,100 | 35,000 | $107,800 | |
| EDSA | Edesa Biotech, Inc. | −657,500 | 30,000 | $156,900 | |
| OABIW | OmniAb, Inc. | −536,955 | 164,045 | $257,550 | |
| PMVP | PMV Pharmaceuticals, Inc. | −442,657 | 708,102 | $878,046 | |
| XFOR | X4 Pharmaceuticals, Inc | −258,264 | 335,309 | $1,384,826 | |
| VRCA | Verrica Pharmaceuticals Inc. | −253,934 | 99,735 | $527,598 | |
| HELP | Cybin Inc. | −205,842 | 134,060 | $643,488 | |
| CGEN | Compugen Ltd | −201,100 | 104,300 | $222,159 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | −194,600 | 269,100 | $629,694 | |
| CABA | Cabaletta Bio, Inc. | −121,100 | 50,000 | $134,500 | |
| KZIA | Kazia Therapeutics Ltd | −115,180 | 345,179 | $2,568,131 | |
| BOLD | Boundless Bio, Inc. | −112,389 | 597,682 | $657,450 | |
| ZVRA | Zevra Therapeutics, Inc. | −89,088 | 480,000 | $4,473,600 | |
| SRZN | Surrozen, Inc./DE | −80,626 | 33,005 | $961,435 | |
| ABEO | Abeona Therapeutics Inc. | −62,918 | 846,587 | $3,792,709 | |
| OVID | Ovid Therapeutics Inc. | −62,367 | 40,000 | $88,800 | |
| NKTR | Nektar Therapeutics | −50,000 | 85,000 | $6,115,750 | |
| XOMA | XOMA Royalty Corp | −45,500 | 69,500 | $2,180,215 | |
| QNRX | Quoin Pharmaceuticals, Ltd. | −24,729 | 53,460 | $352,836 | |
| AYTU | Aytu Biopharma, Inc | −21,415 | 792,289 | $2,162,948 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | −6,454 | 383,462 | $3,600,708 | |
| PLRX | Pliant Therapeutics, Inc. | −5,400 | 224,650 | $283,059 | |
| CBIO | Crescent Biopharma, Inc. | −2,682 | 85,000 | $1,561,450 | |
| EVAX | Evaxion A/S | −287 | 19,713 | $73,332 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
20 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TERN | Terns Pharmaceuticals, Inc. | 100,000 | $5,272,000 | |
| ESTA | Establishment Labs Holdings Inc. | 56,000 | $3,179,680 | |
| SLGL | Sol-Gel Technologies Ltd. | 27,778 | $2,200,573 | |
| CTMX | CytomX Therapeutics, Inc. | 400,000 | $1,880,000 | |
| XERS | Xeris Biopharma Holdings, Inc. | 320,030 | $1,856,174 | |
| SIBN | SI-BONE, Inc. | 114,964 | $1,451,995 | |
| OKYO | OKYO Pharma Ltd | 850,000 | $1,368,500 | |
| ARDX | Ardelyx, Inc. | 150,000 | $898,500 | |
| CNTB | Connect Biopharma Holdings Ltd | 310,000 | $812,200 | |
| MSLE | Satellos Bioscience Inc. | 100,000 | $563,000 | |
| PHAT | Phathom Pharmaceuticals, Inc. | 50,010 | $555,611 | |
| OKUR | OnKure Therapeutics, Inc. | 132,578 | $548,872 | |
| BCAB | BioAtla, Inc. | 65,387 | $526,365 | |
| CADL | Candel Therapeutics, Inc. | 102,500 | $502,250 | |
| POCI | Precision Optics Corporation, Inc. | 100,000 | $439,000 | |
| UPB | Upstream Bio, Inc. | 35,000 | $315,000 | |
| IRD | Opus Genetics, Inc. | 68,688 | $312,530 | |
| ARVN | Arvinas, Inc. | 27,500 | $291,500 | |
| SABS | SAB Biotherapeutics, Inc. | 50,000 | $191,500 | |
| KLRS | Kalaris Therapeutics, Inc. | 20,400 | $117,708 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
13 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 50,000 | $2,622,000 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 100,000 | $2,300,000 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 200,000 | $1,864,000 | |
| SPRB | Spruce Biosciences, Inc. | 19,742 | $1,719,725 | |
| ENTA | Enanta Pharmaceuticals Inc | 100,000 | $1,577,000 | |
| MIST | Milestone Pharmaceuticals Inc. | 662,666 | $1,338,585 | |
| XLO | Xilio Therapeutics, Inc. | 126,270 | $1,131,379 | |
| GERN | Geron Corp | 805,800 | $1,063,656 | |
| KZR | Kezar Life Sciences, Inc. | 156,179 | $982,365 | |
| GOSS | Gossamer Bio, Inc. | 204,770 | $634,787 | |
| FENC | Fennec Pharmaceuticals Inc. | 50,000 | $385,000 | |
| KPRX | Kiora Pharmaceuticals Inc | 131,144 | $258,353 | |
| TNYA | Tenaya Therapeutics, Inc. | 352,001 | $250,624 | |
| No positions match the current search. | ||||
69 positions ·
$364,916,189 total
· as of Mar 31, 2026
Showing 1–50
of 69 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RADX |
Radiopharm Theranostics Ltd
Healthcare
|
Held | 51,000,000 | $219,300,000 | 60.10% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Added | 3,302,300 | $17,502,190 | 4.80% | |
| ADMA |
Adma Biologics, Inc.
Healthcare
|
Added | 1,890,000 | $17,028,900 | 4.67% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
Added | 975,200 | $15,593,448 | 4.27% | |
| EOLS |
Evolus, Inc.
Healthcare
|
Added | 2,179,091 | $8,956,064 | 2.45% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
Added | 1,389,622 | $6,128,233 | 1.68% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Reduced | 85,000 | $6,115,750 | 1.68% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
NEW | 100,000 | $5,272,000 | 1.44% | |
| ZVRA |
Zevra Therapeutics, Inc.
Healthcare
|
Reduced | 480,000 | $4,473,600 | 1.23% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
Reduced | 846,587 | $3,792,709 | 1.04% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
Reduced | 383,462 | $3,600,708 | 0.99% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
NEW | 56,000 | $3,179,680 | 0.87% | |
| KZIA |
Kazia Therapeutics Ltd
Healthcare
|
Reduced | 345,179 | $2,568,131 | 0.70% | |
| ANTX |
AN2 Therapeutics, Inc.
Healthcare
|
Added | 713,845 | $2,441,349 | 0.67% | |
| ARE |
Alexandria Real Estate Equities, Inc.
Real Estate
|
Held | 50,000 | $2,321,000 | 0.64% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Held | 100,000 | $2,226,000 | 0.61% | |
| SLGL |
Sol-Gel Technologies Ltd.
Healthcare
|
NEW | 27,778 | $2,200,573 | 0.60% | |
| XOMA |
XOMA Royalty Corp
Healthcare
|
Reduced | 69,500 | $2,180,215 | 0.60% | |
| AYTU |
Aytu Biopharma, Inc
Healthcare
|
Reduced | 792,289 | $2,162,948 | 0.59% | |
| CRIS |
Curis Inc
Healthcare
|
Added | 3,726,406 | $2,049,523 | 0.56% | |
| HRTX |
Heron Therapeutics, Inc. /De/
Healthcare
|
Added | 2,402,191 | $1,921,752 | 0.53% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
NEW | 400,000 | $1,880,000 | 0.52% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
NEW | 320,030 | $1,856,174 | 0.51% | |
| TELA |
TELA Bio, Inc.
Healthcare
|
Added | 2,617,252 | $1,622,696 | 0.44% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Reduced | 957,202 | $1,608,099 | 0.44% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Reduced | 85,000 | $1,561,450 | 0.43% | |
| ACET |
Adicet Bio, Inc.
Healthcare
|
Added | 221,955 | $1,511,513 | 0.41% | |
| SIBN |
SI-BONE, Inc.
Healthcare
|
NEW | 114,964 | $1,451,995 | 0.40% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Reduced | 335,309 | $1,384,826 | 0.38% | |
| OKYO |
OKYO Pharma Ltd
Healthcare
|
NEW | 850,000 | $1,368,500 | 0.38% | |
| MNKD |
Mannkind Corp
Healthcare
|
Added | 516,300 | $1,264,935 | 0.35% | |
| LUNG |
Pulmonx Corp
Healthcare
|
Added | 768,288 | $991,091 | 0.27% | |
| INAB |
In8bio, Inc.
Healthcare
|
Added | 663,412 | $981,849 | 0.27% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Reduced | 33,005 | $961,435 | 0.26% | |
| DCTH |
Delcath Systems, Inc.
Healthcare
|
Added | 100,000 | $928,000 | 0.25% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
NEW | 150,000 | $898,500 | 0.25% | |
| PMVP |
PMV Pharmaceuticals, Inc.
Healthcare
|
Reduced | 708,102 | $878,046 | 0.24% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
Added | 50,000 | $874,500 | 0.24% | |
| CNTB |
Connect Biopharma Holdings Ltd
Healthcare
|
NEW | 310,000 | $812,200 | 0.22% | |
| MXCT |
Maxcyte, Inc.
Healthcare
|
Added | 1,004,673 | $706,285 | 0.19% | |
| CDXS |
Codexis, Inc.
Healthcare
|
Added | 417,994 | $681,330 | 0.19% | |
| BOLD |
Boundless Bio, Inc.
Healthcare
|
Reduced | 597,682 | $657,450 | 0.18% | |
| HELP |
Cybin Inc.
Healthcare
|
Reduced | 134,060 | $643,488 | 0.18% | |
| ZNTL |
Zentalis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 269,100 | $629,694 | 0.17% | |
| KTTA |
Pasithea Therapeutics Corp.
Healthcare
|
Added | 831,301 | $616,825 | 0.17% | |
| MSLE |
Satellos Bioscience Inc.
Healthcare
|
NEW | 100,000 | $563,000 | 0.15% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
NEW | 50,010 | $555,611 | 0.15% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
NEW | 132,578 | $548,872 | 0.15% | |
| VRCA |
Verrica Pharmaceuticals Inc.
Healthcare
|
Reduced | 99,735 | $527,598 | 0.14% | |
| BCAB |
BioAtla, Inc.
Healthcare
|
NEW | 65,387 | $526,365 | 0.14% |